We’d love to hear your feedback on this activity. It helps us to continually improve our products.
Please provide feedback for this on the following(scale 1-5, 1 strongly disagree; 5 strongly agree):
* = Mandatory Field
The COP-AF trial looked at the use of anti-inflammatory colchicine in patients undergoing major noncardiac thoracic surgery and reducing risk of cardiovascular complications, especially perioperative atrial fibrillation and myocardial injury after noncardiac surgery (MINS). We spoke to Prof. David Conen (Population Health Research Institute, Hamilton, ON, Canada), principle investigator of COP-AF and presenter at the […]
Presented at the European Society of Cardiology Congress (ESC Congress) 2023 Amsterdam, the OPERA-AI trial compared the use of handheld echocardiography analysed by artificial intelligence (AI) to ‘cart-based’ echocardiography reported by humans, to help diagnose suspected heart failure. In this touchCARDIO interview, we speak to Dr. Ross Campbell (University of Glasgow, Glasgow, UK) to discuss the […]
The annual conference of the European Society of Cardiology (ESC Congress 2023) recently ended following an insightful few days in the beautiful city of Amsterdam. Taking place between Friday 25 – Monday 28 August, ESC Congress 2023 saw over 30,000 participants and 4,500 faculty and presenters come together to discuss the very latest advances in […]
The HEART-FID trial built on research from the AFFIRM-AHF and IRONMAN trials to investigate the use of intravenous iron in treating heart failure with iron deficiency. In this touchCARDIO interview, we speak to Dr. Robert Mentz (Duke University, NC, US) regarding the HEART-FID trial, presented at the European Society of Cardiology Congress (ESC Congress) 2023 […]
The OptiVALL study aimed to assess the atrioventricular synchronous pacing capabilities of the Micra AV device, and to describe what programming changes are needed. In this touchCARDIO interview, we speak with Dr Sem Briongos Figuero (Hospital Infanta Leonor, Madrid, Spain) to discuss the purpose, design and findings of the OptiVALL study, as well as the […]
The MARVEL 2 trial studied atrioventricular synchronous pacing in patients with a Micra leadless ventricular pacemaker. In this touchCARDIO interview, we speak with Dr Sem Briongos Figuero (Hospital Infanta Leonor, Madrid, Spain) to discuss the trials studying atrioventricular synchrony and their limitations. Sem Briongos Figuero presented an abstract entitled ‘Optimizing atrial sensing parameters in leadless […]
The AdaptResponse trial was designed to assess two methods of restoring resynchronization to the heart in patients with heart failure with left bundle branch block. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the design of the AdaptResponse trial, the outcomes as well as the clinical […]
Cardiac resynchronization therapy is designed to restore the electrical activation in a more natural way in patients with heart failure. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the treatment paradigm with focus on cardiac resynchronization therapy for patients with heart failure. Bruce Wilkoff presented an […]
Recently it has been shown that NT-proBNP may be a useful tool for finding people with an increased risk of atrial fibrillation and stroke. In this touchCARDIO interview, we speak with Dr Søren Zöga Diederichsen (Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark) to discuss the post hoc analysis of the LOOP study. The abstract entitled ‘Atrial […]
Get the latest clinical insights from touchCARDIO